Nutraceuticals target androgen receptor-splice variants (AR-SV) to manage castration resistant prostate cancer (CRPC)

Keyphrases

• Nutraceuticals 100%
• Castration-resistant Prostate Cancer 100%
• Androgen Receptor 80%
• Prostate Cancer 40%
• Natural Compounds 40%
• Adverse Effects 20%
• Ligand-binding Domain 20%
• Genetic mutation 20%
• Anti-androgen Therapy 20%
• Therapeutic Efficacy 20%
• Splice Variant 20%
• Low Toxicity 20%
• Chemoresistant 20%
• Toxicity Profile 20%
• Natural Derivatives 20%
• Complex Tumor 20%
• Tumor Environment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Androgen Receptor 100%
• Castration Resistant Prostate Cancer 100%
• Functional Food 100%
• Natural Product 20%
• Prostate Cancer 20%
• Neoplasm 10%
• Bioavailability 10%
• Antiandrogen 10%
• Combination Therapy 10%
• Diseases 10%

Medicine and Dentistry

• Antiandrogen Therapy 10%
• Ligand Binding Domain 10%